Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra versus usual treatment for acute gout
NL-OMON28223Recruiting
- Sponsor
- prof. dr. M.A.F.J. van de Laar
- Start
- Dec 2015
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of anakinra in gout (2 arms), sponsored by prof. dr. M.A.F.J. van de Laar. Primary endpoint: Primary: change in patient-reported pain in the index joint. Started Dec 2015; status: recruiting.
02
Drugs
anakinra
03
Conditions
gout
Beyond the preview
Go deeper on NL-OMON28223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28223.